AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
176 hedge funds and large institutions have $979M invested in Avadel Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 58 increasing their positions, 43 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
27% less call options, than puts
Call options by funds: $35.8M | Put options by funds: $48.9M
28% less capital invested
Capital invested by funds: $1.36B → $979M (-$376M)
Holders
176
Holding in Top 10
8
Calls
$35.8M
Puts
$48.9M
Top Buyers
| 1 | +$28.3M | |
| 2 | +$14.7M | |
| 3 | +$9.27M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$9.01M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$7.47M |
Top Sellers
| 1 | -$26.3M | |
| 2 | -$19.6M | |
| 3 | -$14M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$11M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$7.34M |